{"date":"2026-08-14","count":35,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4128-2026-08-14-1838-1fn6m1q","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2026-08-14","time":"18:38:53","subject":"子公司中天（上海）與合一生技共同研發之SNS812小核酸新冠新藥第II期人體臨床試驗成果，於國際高影響力SCI期刊《Journal of Biomedical Science》發表","clause":"第53款","fact_date":"2026-08-14","cite_as":"公開資訊觀測站重大訊息：中天（4128），2026-08-14 18:38，「子公司中天（上海）與合一生技共同研發之SNS812小核酸新冠新藥第II期人體臨床試驗成果，於國際高影響力SCI期刊《Jo」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2026-08-14-1835-14xopy3","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-14","time":"18:35:41","subject":"更正本公司115年第2季個別財務報告iXBRL申報資訊","clause":"第44款","fact_date":"2026-08-14","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2026-08-14 18:35，「更正本公司115年第2季個別財務報告iXBRL申報資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-08-14-1818-zub84j","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-08-14","time":"18:18:54","subject":"本公司董事會決議第4次買回庫藏股","clause":"第35款","fact_date":"2026-08-14","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-08-14 18:18，「本公司董事會決議第4次買回庫藏股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2026-08-14-1810-rvfy9r","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2026-08-14","time":"18:10:03","subject":"本公司與中天（上海）共同研發之SNS812小核酸新冠新藥第II期人體臨床試驗成果，於國際高影響力SCI期刊《Journal ofBiomedical Science》發表","clause":"第53款","fact_date":"2026-08-14","cite_as":"公開資訊觀測站重大訊息：合一（4743），2026-08-14 18:10，「本公司與中天（上海）共同研發之SNS812小核酸新冠新藥第II期人體臨床試驗成果，於國際高影響力SCI期刊《Journa」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4120-2026-08-14-1742-a0fqus","company_id":"4120","company":"友華","market":"上櫃","industry":"生技醫療","date":"2026-08-14","time":"17:42:09","subject":"115年第二季合併財務報告業經董事會通過","clause":"第31款","fact_date":"2026-08-14","cite_as":"公開資訊觀測站重大訊息：友華（4120），2026-08-14 17:42，「115年第二季合併財務報告業經董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2026-08-14-1735-ozqyjx","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2026-08-14","time":"17:35:02","subject":"本公司受邀參加國票綜合證券舉辦之法人說明會","clause":"第12款","fact_date":"2026-08-17","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2026-08-14 17:35，「本公司受邀參加國票綜合證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2026-08-14-1728-1tjcb3f","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2026-08-14","time":"17:28:27","subject":"更正本公司115年第2季合併財務報告書及iXBRL財報申報","clause":"第53款","fact_date":"2026-08-14","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2026-08-14 17:28，「更正本公司115年第2季合併財務報告書及iXBRL財報申報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2026-08-14-1716-1u89yqv","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2026-08-14","time":"17:16:04","subject":"公告本公司舉辦115年第二次線上法說會事宜","clause":"第12款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：合一（4743），2026-08-14 17:16，「公告本公司舉辦115年第二次線上法說會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2026-08-14-1655-rr6mt9","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-08-14","time":"16:55:41","subject":"公告本公司提報董事會民國115年第二季合併財務報告","clause":"第43款","fact_date":"2026-08-14","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2026-08-14 16:55，「公告本公司提報董事會民國115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-08-14-1655-7rmvha","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-08-14","time":"16:55:39","subject":"更正115年5月關係人交易申報資訊","clause":"第51款","fact_date":"2026-08-14","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-08-14 16:55，「更正115年5月關係人交易申報資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-08-14-1638-1b9r7vd","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-08-14","time":"16:38:02","subject":"公告本公司115年第二季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2026-08-14","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-08-14 16:38，「公告本公司115年第二季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2026-08-14-1616-qmd25j","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2026-08-14","time":"16:16:18","subject":"公告本公司取得簽證會計師內部控制專案審查報告","clause":"第25款","fact_date":"2026-08-14","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2026-08-14 16:16，「公告本公司取得簽證會計師內部控制專案審查報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2026-08-14-1611-16ymvc7","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2026-08-14","time":"16:11:46","subject":"公告本公司董事會通過115年度上半年度合併財務報告","clause":"第43款","fact_date":"2026-08-14","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2026-08-14 16:11，「公告本公司董事會通過115年度上半年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2026-08-14-1602-117ky8b","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2026-08-14","time":"16:02:34","subject":"公告本公司第二次買回庫藏股期間屆滿及執行情形","clause":"第35款","fact_date":"2026-08-15","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2026-08-14 16:02，「公告本公司第二次買回庫藏股期間屆滿及執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2026-08-14-1600-dgpq5s","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2026-08-14","time":"16:00:29","subject":"公告本公司發言人、財務主管、會計主管暨公司治理主管異動","clause":"第8款","fact_date":"2026-08-14","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2026-08-14 16:00，「公告本公司發言人、財務主管、會計主管暨公司治理主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4746-2026-08-14-1544-100esni","company_id":"4746","company":"台耀","market":"上市","industry":"生技醫療","date":"2026-08-14","time":"15:44:44","subject":"公告本公司研發主管異動","clause":"第8款","fact_date":"2026-08-14","cite_as":"公開資訊觀測站重大訊息：台耀（4746），2026-08-14 15:44，「公告本公司研發主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2026-08-14-1543-7ne4z1","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-08-14","time":"15:43:49","subject":"代重要子公司台灣泰福生技股份有限公司公告辦理減資變更登記完成","clause":"第36款","fact_date":"2026-08-14","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-08-14 15:43，「代重要子公司台灣泰福生技股份有限公司公告辦理減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8436-2026-08-14-1541-kmgkzx","company_id":"8436","company":"大江","market":"上櫃","industry":"生技醫療","date":"2026-08-14","time":"15:41:40","subject":"公告本公司調整115年分派股東現金股利配息率","clause":"第14款","fact_date":"2026-08-14","cite_as":"公開資訊觀測站重大訊息：大江（8436），2026-08-14 15:41，「公告本公司調整115年分派股東現金股利配息率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2026-08-14-1541-1hyejn3","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2026-08-14","time":"15:41:15","subject":"更正本公司115年第2季合併財報及iXBRL部分公告資訊","clause":"第44款","fact_date":"2026-08-14","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2026-08-14 15:41，「更正本公司115年第2季合併財報及iXBRL部分公告資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-08-14-1523-6uq6ub","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-08-14","time":"15:23:07","subject":"公告本公司董事會決議115年度限制員工權利新股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-08-14 15:23，「公告本公司董事會決議115年度限制員工權利新股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-08-14-1522-t64vw9","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-08-14","time":"15:22:30","subject":"公告本公司董事會追認修訂「115年度限制員工權利新股發行辦法」","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-08-14 15:22，「公告本公司董事會追認修訂「115年度限制員工權利新股發行辦法」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-08-14-1522-5xp9q1","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-08-14","time":"15:22:00","subject":"公告本公司配合會計師事務所內部調整更換簽證會計師","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-08-14 15:22，「公告本公司配合會計師事務所內部調整更換簽證會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-08-14-1521-1v2ev5p","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-08-14","time":"15:21:31","subject":"公告本公司提報董事會115年第二季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-08-14 15:21，「公告本公司提報董事會115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2026-08-14-1507-1jixu6b","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2026-08-14","time":"15:07:33","subject":"公告本公司董事會決議召開115年第一次股東臨時會相關事宜","clause":"第32款","fact_date":"2026-08-14","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2026-08-14 15:07，「公告本公司董事會決議召開115年第一次股東臨時會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-08-14-1444-n0me4v","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-08-14","time":"14:44:39","subject":"本公司受邀參加華南永昌證券舉辦之投資論壇","clause":"第12款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-08-14 14:44，「本公司受邀參加華南永昌證券舉辦之投資論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2026-08-14-1443-10qx3kw","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2026-08-14","time":"14:43:17","subject":"公告本公司董事會決議不繼續辦理現金增資發行新股案","clause":"第44款","fact_date":"2026-08-14","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2026-08-14 14:43，「公告本公司董事會決議不繼續辦理現金增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2026-08-14-1442-zmvzyw","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2026-08-14","time":"14:42:52","subject":"公告本公司董事會決議新委任第二屆薪資報酬委員會委員","clause":"第6款","fact_date":"2026-08-14","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2026-08-14 14:42，「公告本公司董事會決議新委任第二屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2026-08-14-1442-19x80n4","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2026-08-14","time":"14:42:17","subject":"公告本公司第二屆新任審計委員會委員","clause":"第6款","fact_date":"2025-08-14","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2026-08-14 14:42，「公告本公司第二屆新任審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2026-08-14-1435-17qvvm5","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2026-08-14","time":"14:35:30","subject":"公告本公司董事會通過115年第二季財務報告","clause":"第43款","fact_date":"2026-08-14","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2026-08-14 14:35，「公告本公司董事會通過115年第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2026-08-14-1435-1xnu34j","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-08-14","time":"14:35:22","subject":"本公司受邀參加櫃買中心業績發表會","clause":"第12款","fact_date":"2026-08-17","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-08-14 14:35，「本公司受邀參加櫃買中心業績發表會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-08-14-1417-c63gfi","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-08-14","time":"14:17:11","subject":"公告本公司技術長異動","clause":"第11款","fact_date":"2026-08-14","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-08-14 14:17，「公告本公司技術長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7726-2026-08-14-1336-1kuvst7","company_id":"7726","company":"暄達","market":"興櫃","industry":"生技醫療","date":"2026-08-14","time":"13:36:44","subject":"更正本公司115年度第2季合併財報XBRL申報資訊-會計師核閱報告保留意見種類","clause":"第44款","fact_date":"2026-08-14","cite_as":"公開資訊觀測站重大訊息：暄達（7726），2026-08-14 13:36，「更正本公司115年度第2季合併財報XBRL申報資訊-會計師核閱報告保留意見種類」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6709-2026-08-14-1230-10da4az","company_id":"6709","company":"昱厚生技","market":"興櫃","industry":"生技醫療","date":"2026-08-14","time":"12:30:02","subject":"公告本公司董事會通過研發主管異動","clause":"第11款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：昱厚生技（6709），2026-08-14 12:30，「公告本公司董事會通過研發主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6709-2026-08-14-1229-1prmq7a","company_id":"6709","company":"昱厚生技","market":"興櫃","industry":"生技醫療","date":"2026-08-14","time":"12:29:45","subject":"公告本公司民國115年第二季財務報表業經提報董事會通過","clause":"第43款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：昱厚生技（6709），2026-08-14 12:29，「公告本公司民國115年第二季財務報表業經提報董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-08-14-1159-yniuci","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-08-14","time":"11:59:34","subject":"公告本公司董事會通過115年度第二季合併財務報告","clause":"第43款","fact_date":"2026-08-12","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-08-14 11:59，「公告本公司董事會通過115年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}